Nova Eye Medical (ELXMF) Financial Statements
Nova Eye Medical Financial Overview
Nova Eye Medical's market cap is currently $30.04M. The company's EPS TTM is $-0.02; its P/E ratio is -9.87; and it has a dividend yield of 91.92%. Nova Eye Medical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 34.87M | $ 29.27M | $ 23.32M | $ 17.02M | $ 13.38M |
| Gross Profit | $ 25.01M | $ 20.07M | $ 20.19M | $ 842.00K | $ -765.00K |
| Operating Income | $ -4.38M | $ -11.25M | $ -8.97M | $ -11.85M | $ -9.88M |
| EBITDA | $ -2.21M | $ -8.98M | $ -5.98M | $ -14.65M | $ -7.89M |
| Net Income | $ -4.33M | $ -9.06M | $ -8.79M | $ -15.29M | $ -7.50M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 964.00K | $ 5.05M | $ 6.15M | $ 7.42M | $ 8.00M |
| Total Assets | $ 21.59M | $ 26.50M | $ 29.88M | $ 30.36M | $ 36.63M |
| Total Debt | $ 2.39M | $ 3.02M | $ 3.35M | $ 1.53M | $ 1.94M |
| Net Debt | $ 1.43M | $ -2.04M | $ -2.80M | $ -5.89M | $ -6.06M |
| Total Liabilities | $ 7.31M | $ 7.54M | $ 8.55M | $ 7.17M | $ 6.23M |
| Stockholders' Equity | $ 14.28M | $ 18.97M | $ 21.33M | $ 23.19M | $ 30.40M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.36M | $ -6.58M | $ -8.31M | $ -7.52M | $ -10.27M |
| Operating Cash Flow | $ -3.12M | $ -6.15M | $ -7.86M | $ -6.72M | $ -4.68M |
| Investing Cash Flow | $ -388.00K | $ -364.00K | $ -325.00K | $ -800.00K | $ -4.58M |
| Financing Cash Flow | $ -657.00K | $ 5.56M | $ 6.91M | $ 6.82M | $ -402.00K |
Currency in AUD